» Articles » PMID: 34031216

LINC00997/MicroRNA 574-3p/CUL2 Promotes Cervical Cancer Development Via Mitogen-Activated Protein Kinase Signaling

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2021 May 25
PMID 34031216
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical cancer (CC) is a common gynecological malignancy with high morbidity and mortality. Mounting evidence has highlighted that long noncoding RNAs are essential regulators in cancer development. Long intergenic non-protein-coding RNA 997 (LINC00997) was identified for study due to its high expression in CC tissues. The aim of the study was to investigate the function and mechanism of LINC00997 in CC. Reverse transcription-quantitative PCR (RT-qPCR) revealed that LINC00997 RNA expression was also increased in CC cells and LINC00997 copy number was upregulated in CC tissues. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), colony formation, and Transwell assays as well as transmission electron microscopy observation exhibited that LINC00997 depletion inhibited CC cell proliferation, migration, invasion, and autophagy. The relationship between LINC00997 and its downstream genes was confirmed by RNA pulldown, luciferase reporter, and RNA-binding protein immunoprecipitation assays. Mechanistically, LINC00997 upregulated the expression of cullin 2 (CUL2) by interacting with microRNA 574-3p (miR-574-3p). Moreover, Western blot analysis was employed to detect the protein levels of mitogen-activated protein kinase (MAPK) pathway-associated factors in CC cells. LINC00997 activated the MAPK signaling by increasing CUL2 expression, thus promoting malignant phenotypes of CC cells. In conclusion, the LINC00997/miR-574-3p/CUL2 axis contributes to CC cell proliferation, migration, invasion, and autophagy via the activation of MAPK signaling.

Citing Articles

The Roles of Autophagy-related miRNAs in Gynecologic Tumors: A Review of Current Knowledge for Possible Targeted Therapy.

Mobinikhaledi M, Faridzadeh A, Farkhondeh T, Pourhanifeh M, Samarghandian S Curr Mol Med. 2024; 24(10):1269-1281.

PMID: 39300715 DOI: 10.2174/0115665240263059231002093454.


Comprehensive prognostic and immunological analysis of Cullin2 in pan-cancer and its identification in hepatocellular carcinoma.

Jia L, Zhang X, Zhou T, Xie J, Jin J, Zhang D Aging (Albany NY). 2024; 16(10):8898-8921.

PMID: 38787355 PMC: 11164483. DOI: 10.18632/aging.205848.


MicroRNA-154-5p suppresses cervical carcinoma growth and metastasis by silencing Cullin2 and .

Li Y, Wei Y, Zhang H, Bai Y, Wang X, Li Q PeerJ. 2023; 11:e15641.

PMID: 37397007 PMC: 10312157. DOI: 10.7717/peerj.15641.


Comprehensive Expression Profiling and Molecular Basis of CDC28 Protein Kinase Regulatory Subunit 2 in Cervical Cancer.

Qin L, Luo X, Qin X, Huang H, Zhang L, Chen S Int J Genomics. 2022; 2022:6084549.

PMID: 35935749 PMC: 9352497. DOI: 10.1155/2022/6084549.


The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer.

Yang Q, Al-Hendy A Cells. 2022; 11(7).

PMID: 35406713 PMC: 8998012. DOI: 10.3390/cells11071149.

References
1.
Shao S, Wang C, Wang S, Zhang H, Zhang Y . LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis. Biomed Pharmacother. 2019; 117:109082. DOI: 10.1016/j.biopha.2019.109082. View

2.
Wang M, Zhang R, Zhang S, Xu R, Yang Q . MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells. Gene. 2019; 700:110-119. DOI: 10.1016/j.gene.2019.03.043. View

3.
Wang X, Zhang W . Long non-coding RNA cancer susceptibility candidate 2 inhibits the cell proliferation, invasion and angiogenesis of cervical cancer through the MAPK pathway. Eur Rev Med Pharmacol Sci. 2019; 23(8):3261-3269. DOI: 10.26355/eurrev_201904_17687. View

4.
Lou W, Ding B, Fu P . Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Front Cell Dev Biol. 2020; 8:85. PMC: 7058547. DOI: 10.3389/fcell.2020.00085. View

5.
Antunes F, Erustes A, Costa A, Nascimento A, Bincoletto C, Ureshino R . Autophagy and intermittent fasting: the connection for cancer therapy?. Clinics (Sao Paulo). 2018; 73(suppl 1):e814s. PMC: 6257056. DOI: 10.6061/clinics/2018/e814s. View